Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...
Gallego led comfortably after the first results were released on election night, but his lead narrowed as more ballots were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback